Need Help? Call 1­-866-­796-­7386
« back to stock screener

  HBIO stock: Harvard Bioscience, Inc.

Current Rating
Buy

Previous Rating

Strong Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$3.01
Market Cap
132M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
1.7
P/S
1.23
Dividend %
-
P/CF
-
P/FCF
13.8
Op. Cash Flow
10.6K
FCF
0.2
Op. Margin
-2.30%
Net Margin
-7.70%
ROE
-10.50%
ROI
0.90%
ROA
-5.10%
EPS Growth
-
Current Ratio
2.1
Debt/Equity
57.40%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
ImmuCell Corporation (ICCC) $5.43 - - 38.6M Strong Buy
Lannett Company, Inc. (LCI) $6.11 - - 208.2M Strong Buy
Titan Pharmaceuticals, Inc. (TTNP) $0.21 - - 23M Strong Buy
Teva Pharmaceutical Industries (TEVA) $8.82 - - 10.43B Strong Buy
STRATA Skin Sciences Inc (SSKN) $1.37 - - 54.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More